Supplier log in
Laboratory Test Product and Services: Severe Combined Immunodeficiency (SCID); Spinal Muscular Atrophy (SMA);
Details
|
Tender Closed
|
|
| RFx ID : | 27306300 |
| Tender Name : | Laboratory Test Product and Services: Severe Combined Immunodeficiency (SCID); Spinal Muscular Atrophy (SMA); |
| Reference # : | P23-524 |
| Open Date : | Friday, 28 April 2023 8:30 AM (Pacific/Auckland UTC+12:00) |
| Close Date : | Friday, 16 June 2023 12:00 PM (Pacific/Auckland UTC+12:00) |
| Tender Type : | Request for Proposals (RFP) |
| Tender Coverage : | Sole Agency [?] |
| Categories : |
|
| Regions: |
|
| Exemption Reason : | None |
| Required Pre-qualifications : | None |
| Contact : |
Bernard Wong Bernard.Wong@healthsourcenz.co.nz |
| Alternate Physical Delivery Address : | |
| Alternate Physical Fax Number : | |
The scope of this Request for Proposal (RFP) is twofold:
(1) Primary Procurement:
To establish a Supplier Panel for the supply of loan laboratory equipment with consumables/reagent and maintenance services for the performance of the following tests
(a) Severe Combined Immunodeficiency (SCID);
(b) Spinal Muscular Atrophy (SMA);
(2) Immediate Secondary Procurement Opportunities (Capital funding is subject to each District’s Delegated Financial Authority (DFA) Approval):
To invite secondary procurement proposals from suppliers who are applying for the Supplier Panel and who wish to enter into an agreement to supply the following equipment to the Districts listed below who have an immediate requirement:
For avoidance of doubt, the Supplier can submit proposals on any or all of the individual Categorised tests, below, with the overall objective of sourcing the most technically and cost effective solution for the various Categories as a whole.
(a) Secondary Procurement Opportunity 1 (SPO1)
Te Toka Tumai Auckland District (Te Toka Tumai) is exploring a re-agent technology solution which is capable of performing Severe Combined Immunodeficiency (SCID) tests.
and / or
(b) Secondary Procurement Opportunity 2 (SPO2)
Te Toka Tumai Auckland District (Te Toka Tumai) is exploring a re-agent technology solution which is capable of performing Spinal Muscular Atrophy (SMA) tests tests.
